Company Overview of ImmunoGenes AG
ImmunoGenes AG, a biopharmaceutical company, generates transgenic animals for the production of polyclonal and monoclonal antibodies. Its transgenic FcRn technology genetically alters animals and enhances the antibody production, as well as decreases the time of harvest. The company was founded in 2007 and is based in Baar, Switzerland.
Founded in 2007
Key Executives for ImmunoGenes AG
Similar Private Companies By Industry
|Arrayon Biotechnology SA||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact ImmunoGenes AG, please visit www.immunogenes.com. Company data is provided by Capital IQ. Please use this form to report any data issues.